The study found significantly heightened serum levels of FGF-21 and GDF-15 in patients with migraine compared to a control group, which suggests that both cytokines may have potential value in distinguishing between migraine sufferers and healthy controls. This evidence concerns the gene FGF21 and migraine disorder.